日韩av大片在线观看欧美成人不卡|午夜先锋看片|中国女人18毛片水多|免费xx高潮喷水|国产大片美女av|丰满老熟妇好大bbbbbbbbbbb|人妻上司四区|japanese人妻少妇乱中文|少妇做爰喷水高潮受不了|美女人妻被颜射的视频,亚洲国产精品久久艾草一,俄罗斯6一一11萝裸体自慰,午夜三级理论在线观看无码

德潤誠（北京）生物科技有限公司
中級會員 | 第4年

13811559904

Matriks Biotek

參  考  價面議
具體成交價以合同協(xié)議為準

產(chǎn)品型號

品       牌

廠商性質(zhì)代理商

所  在  地

更新時間：2024-03-11 13:57:47瀏覽次數(shù)：401次

聯(lián)系我時,，請告知來自 化工儀器網(wǎng)
同類優(yōu)質(zhì)產(chǎn)品更多>
MatriksBiotekMatriksBiotek公司成立于2002年,，專門生產(chǎn)針對抗體藥的ELISA試劑盒,，用于檢測抗體藥的體內(nèi)濃度或因使用抗體藥而產(chǎn)生的抗體的體內(nèi)濃度

Matriks Biotek 


Matriks Biotek公司成立于2002年,，專門生產(chǎn)針對抗體藥的ELISA試劑盒,，用于檢測抗體藥的體內(nèi)濃度或因使用抗體藥而產(chǎn)生的抗體的體內(nèi)濃度,。Matriks Biotek產(chǎn)品達到ISO 13485 & CE IVD標準,。目前，在30個國家有超過25個的大型制藥企業(yè)都在使用其產(chǎn)品,。   


抗體藥（Monoclonal Antibody Drugs）是一類相對新型的生物制劑,，是一類使用人工合成的單克隆抗體作為藥物治療的藥物?？贵w藥這些抗體藥物通過特異性地結(jié)合目標分子或細胞表面受體,，發(fā)揮治療作用?？贵w藥物具有高度的特異性和親和力,，可以選擇性地結(jié)合目標分子或細胞表面受體，從而干擾或調(diào)節(jié)生物過程,。因此,，檢測抗體藥血藥濃度及機體針對抗體藥產(chǎn)生的抗體水平對指導治療和個性化用藥具有重要意義,。目前，大量的臨床和制藥企業(yè)都在從事該項研究,。   


抗體藥物已被廣泛應用于多種疾病的治療,，包括腫瘤、自身免疫性疾病,、傳染病等,。它們可以作為單獨的治療藥物使用，也可以與其他藥物聯(lián)合應用,，以增強治療效果,。   


作為Matriks Biotek在中國區(qū)域的代理，科技有限公司將為中國客戶提供全面的Matriks Biotek產(chǎn)品,。

下圖為Matriks Biotek科技有限公司（AmyJet Scientific Inc.）作為Matriks Biotek在中國區(qū)域的代理書。  


Matriks Biotek特色產(chǎn)品推薦：

MTB-COR-QNS-IGG-SRBDCORONAHUNTER (Q-CORSRBD IgG) anti-Spike RBD IgG ELISA
MTB-COR-QNS-IGG-S1CORONAHUNTER (Q-CORS1 IgG) anti-Spike 1 IgG ELISA
MTB-COR-QNS-IGG-NCPCORONAHUNTER (Q-CORN IgG) anti-Nucleocapsid IgG  ELISA
MTB-COR-QNS-IGG-STRIMCORONAHUNTER (Q-CORS IgG) anti-S Trimer IgG ELISA
MTB-COR-QNS-IGM-SRBDCORONAHUNTER (Q-CORSRBD IgM) anti-Spike RBD IgM ELISA
MTB-COR-QNS-IGM-S1CORONAHUNTER (Q-CORS1 IgM) anti-Spike 1 IgM ELISA
MTB-COR-QNS-IGM-NCPCORONAHUNTER (Q-CORN IgM) anti-Nucleocapsid IgM  ELISA
MTB-COR-QNS-IGM-STRIMCORONAHUNTER (Q-CORS IgM) anti-S Trimer IgM ELISA
MTB-COR-QNS-IGA-SRBDCORONAHUNTER (Q-CORSRBD IgA) anti-Spike RBD IgA ELISA
MTB-COR-QNS-IGA-S1CORONAHUNTER (Q-CORS1 IgA) anti-Spike 1 IgA ELISA
MTB-COR-QNS-IGA-NCPCORONAHUNTER (Q-CORN IgA) anti-Nucleocapsid IgA ELISA
MTB-COR-QNS-IGA-STRIMCORONAHUNTER (Q-CORS IgA) anti-S Trimer IgA ELISA
MTB-COR-QNS-IGE-SRBDCORONAHUNTER (Q-CORSRBD IgE) anti-Spike RBD IgE ELISA
MTB-COR-QNS-IGE-S1CORONAHUNTER (Q-CORS1 IgE) anti-Spike 1 IgE ELISA
MTB-COR-QNS-IGE-NCPCORONAHUNTER (Q-CORN-SRBD IgE) anti-Nucleocapsid-S RBD IgE ELISA
MTB-COR-QNS-IGE-STRIMCORONAHUNTER (Q-CORS IgE) anti-S Trimer IgE ELISA
MTB-INF-FD-REMIShikari (Q-INFLIXI) Infliximab (Remicade) ELISA
MTB-INF-SPEC-INFShikari (QS-INFLIXI) Infliximab (Remicade) ELISA
MTB-INF-QLS-REMIShikari (Q-ATI) Infliximab (Remicade) ELISA
MTB-INF-QNS-REMIShikari (Q-ATI) w/confirmation Infliximab (Remicade) ELISA
MTB-INF-QNFT-REMIShikari (Q-ATIDUO) Infliximab (Remicade) ELISA
MTB-INF-FD-REMSShikari (Q-REMS) Infliximab (Remsima) ELISA
MTB-INF-QLS-REMSShikari (S-AIR) Qualitative Infliximab (Remsima) ELISA
MTB-INF-QNS-REMSShikari (S-AIR) w/confirmation Infliximab (Remsima) ELISA
MTB-INF-QNFT-REMSShikari (S-AIR) Total semiquantitative Infliximab (Remsima) ELISA
MTB-ADA-FD-HUMShikari (Q-ADA) Adalimumab (Humira) ELISA
MTB-ADA-SPEC-ADAShikari (QS-ADA) Adalimumab (Humira) ELISA
MTB-ADA-QLS-HUMShikari (S-ATA)-Qualitative Adalimumab (Humira) ELISA
MTB-ADA-QNS-HUMShikari (S-ATA) w/confirmation Adalimumab (Humira) ELISA
MTB-ADA-QNFT-HUMShikari (S-ATA)-Free/Total semiquantitative Adalimumab (Humira) ELISA
MTB-ETA-FD-ENBShikari (Q-ETA) Etanercept (Enbrel) ELISA
MTB-ETA-QLS-ENBShikari (S-ATE) Etanercept (Enbrel) ELISA
MTB-GOL-FD-SIMShikari (Q-GOL) Golimumab (Simponi) ELISA
MTB-GOL-QLS-SIMShikari (S-ATG) Golimumab (Simponi) ELISA
MTB-GOL-QNS-SIMShikari (S-ATG) w/confirmation Golimumab (Simponi) ELISA
MTB-CER-FD-CIMShikari (Q-CERT) Certolizumab (Cimzia) ELISA
MTB-CER-QNS-CIMShikari (S-ATCER) Certolizumab (Cimzia) ELISA
MTB-VED-SPEC-VEDShikari (QS-VEDO) Vedolizumab (Entyvio) ELISA
MTB-VED-FD-ENTShikari (Q-VEDO) Vedolizumab (Entyvio) ELISA
MTB-VED-QLS-ENTShikari (S-ATV) Vedolizumab (Entyvio) ELISA
MTB-VED-QNS-ENTShikari (S-ATV) w/confirmation Vedolizumab (Entyvio) ELISA
MTB-UST-FD-STEShikari (Q-UST) Ustekinumab (Stelara) ELISA
MTB-UST-SPEC-STEShikari (QS-UST) Ustekinumab (Stelara) ELISA
MTB-UST-QLS-STEShikari (S-ATU) Ustekinumab (Stelara) ELISA
MTB-UST-QNS-STEShikari (S-ATU) w/confirmation Ustekinumab (Stelara) ELISA
MTB-RAM-FD-CYRShikari (Q-RAM) Ramucirumab (Cyramza) ELISA
MTB-RAM-QLS-CYRShikari (S-ATRAM) Ramucirumab (Cyramza) ELISA
MTB-BEV-FD-AAShikari (Q-BEVA) Bevacizumab (Avastin) ELISA
MTB-BEV-QLS-AAShikari (S-ATB) Bevacizumab (Avastin) ELISA
MTB-BEV-QNS-AAShikari (S-ATB) w/confirmation Bevacizumab (Avastin) ELISA
MTB-RIT-FD-RMShikari (Q-RITUX) Rituximab (Rituxan, Mabthera) ELISA
MTB-RIT-QLS-RMShikari (S-ATR) Rituximab (Rituxan, Mabthera) ELISA
MTB-RIT-QNS-RMShikari (S-ATR) w/confirmation Rituximab (Rituxan, Mabthera) ELISA
MTB-TRA-FD-HHShikari (Q-TRAS) Trastuzumab (Herceptin, Herclon) ELISA
MTB-TRA-QLS-HHShikari (S-ATT) Trastuzumab (Herceptin, Herclon) ELISA
MTB-TRA-QNS-HHShikari (S-ATT) w/confirmation Trastuzumab (Herceptin, Herclon) ELISA
MTB-CET-FD-ERBShikari (Q-CET) Cetuximab (Erbitux) ELISA
MTB-CET-QLS-ERBShikari (S-ATC) Cetuximab (Erbitux) ELISA
MTB-CET-QNS-ERBShikari (S-ATC) w/confirmation Cetuximab (Erbitux) ELISA
MTB-DEN-FD-PROShikari (Q-DEN) Denosumab (Prolia) ELISA
MTB-DEN-QLS-PROShikari (S-ATD) Denosumab (Prolia) ELISA
MTB-DEN-QNS-PROShikari  (S-ATD) w/confirmation Denosumab (Prolia) ELISA
MTB-FIL-QNS-FRAShikari (Q-AFA) Filgrastim ELISA
MTB-OMA-FD-XOLShikari (Q-OMA) Omalizumab (Xolair) ELISA
MTB-OMA-QLS-XOLShikari (S-ATO) Omalizumab (Xolair) ELISA
MTB-RAN-FD-LUCShikari (Q-RAN) Ranibizumab (Lucentis) ELISA
MTB-AVE-FD-BAVShikari (Q-AVE) Avelumab (Bavencio) ELISA
MTB-AVE-QLS-BAVShikari (S-ATAV) Avelumab (Bavencio) ELISA
MTB-NIV-FD-OPDShikari (Q-NIVO) Nivolumab (Opdivo) ELISA
MTB-NIV-QLS-OPDShikari (S-ATN) Nivolumab (Opdivo) ELISA
MTB-NIV-QNS-OPDShikari (S-ATN) w/confirmation Nivolumab (Opdivo) ELISA
MTB-PEM-FD-KEYShikari (Q-PEM) Pembrolizumab (Keytruda) ELISA
MTB-PEM-QLS-KEYShikari (S-ATP) Pembrolizumab (Keytruda) ELISA
MTB-PEM-QNS-KEYShikari (S-ATP) w/confirmation Pembrolizumab (Keytruda) ELISA
MTB-IPI-FD-YERShikari (Q-IPI) Ipilimumab (Yervoy) ELISA
MTB-IPI-QLS-YERShikari (S-ATI) Ipilimumab (Yervoy) ELISA
MTB-IPI-QNS-YERShikari (S-ATI) w/confirmation Ipilimumab (Yervoy) ELISA
MTB-TOC-FD-ACTShikari (Q-TOC) Tocilizumab (Actemra) ELISA
MTB-TOC-QLS-ACTShikari (S-ATOC) Tocilizumab (Actemra) ELISA
MTB-TOC-QNS-ACTShikari (S-ATOC) w/confirmation Tocilizumab (Actemra) ELISA
MTB-NAT-FD-TYSShikari (Q-NAT) Natalizumab (Tysabri) ELISA
MTB-NAT-QLS-TYSShikari (S-ATNAT) Natalizumab (Tysabri) ELISA
MTB-NAT-QNS-TYSShikari (S-ATNAT) w/confirmation Natalizumab (Tysabri) ELISA
MTB-AFL-FD-EYLShikari (Q-AF) Aflibercept (Eylea) ELISA
MTB-AFL-FD-SENS-EYLShikari (Q-AF) High Sensitive Aflibercept (Eylea) ELISA
MTB-AFL-QLS-EYLShikari (S-ATAF) Aflibercept (Eylea) ELISA
MTB-AFL-QNS-EYLShikari (S-ATAF) w/confirmation Aflibercept (Eylea) ELISA
MTB-CAN-FD-ILAShikari (Q-CAN) Canakinumab (Ilaris) ELISA
MTB-CAN-QLS-ILAShikari (S-ATCAN) Canakinumab (Ilaris) ELISA
MTB-CAN-QNS-ILAShikari (S-ATCAN) w/confirmation Canakinumab (Ilaris) ELISA
MTB-DUR-FD-IMFShikari (Q-DUR) Durvalumab (Imfinzi) ELISA
MTB-DUR-QLS-IMFShikari (S-ATDUR) Durvalumab (Imfinzi) ELISA
MTB-ATE-FD-TECShikari (Q-ATE) Atezolizumab (Tecentriq) ELISA
MTB-ATE-QLS-TECShikari (S-ATAT) Atezolizumab (Tecentriq) ELISA
MTB-DAR-FD-DARShikari (Q-DAR) Daratumumab (Darzalex) ELISA
MTB-DAR-QLS-DARShikari (S-ATDAR) Daratumumab (Darzalex) ELISA
MTB-ABA-FD-OREShikari (Q-ABA) Abatacept (Orencia) ELISA
MTB-ABA-QLS-OREShikari (S-ATAB) Abatacept (Orencia) ELISA
MTB-ABA-QNS-OREShikari (S-ATAB) w/confirmation Abatacept (Orencia) ELISA
MTB-SEC-FD-VERShikari (Q-SEC) Secukinumab (Cosentyx , Verxant) ELISA
MTB-SEC-QLS-VERShikari (S-ATSEC) Secukinumab (Cosentyx , Verxant) ELISA
MTB-EVO-FD-REPShikari (Q-EVO) Evolocumab (Repatha ) ELISA
MTB-EVO-QLS-REPShikari (S-ATEVO) Evolocumab (Repatha ) ELISA
MTB-PAL-FD-SYNShikari (Q-PAL) Palivizumab (Synagis ) ELISA
MTB-PAL-QLS-SYNShikari (S-ATPAL) Palivizumab (Synagis ) ELISA
MTB-PAL-QNS-SYNShikari (S-ATPAL) w/confirmation Palivizumab (Synagis ) ELISA
MTB-IXE-FD-TALShikari (Q-IXE) Ixekizumab (Taltz ) ELISA
MTB-IXE-QLS-TALShikari (S-ATIXE) Ixekizumab (Taltz ) ELISA
MTB-PER-FD-PERShikari (Q-PER) Pertuzumab (Perjeta ) ELISA
MTB-PER-QLS-PERShikari (S-ATPER) Pertuzumab (Perjeta ) ELISA
MTB-RIS-FD-SKYShikari (Q-RIS) Risankizumab (Skyrizi ) ELISA
MTB-RIS-QLS-SKYShikari (S-ATRIS) Risankizumab (Skyrizi ) ELISA
MTB-RIS-QNS-SKYShikari (S-ATRIS) w/confirmation Risankizumab (Skyrizi ) ELISA
MTB-ECU-FD-SOLShikari (Q-ECU) Eculizumab (Soliris ) ELISA
MTB-ECU-QLS-SOLShikari (S-ATEC) Eculizumab (Soliris ) ELISA
MTB-ECU-QNS-SOLShikari (S-ATEC) w/confirmation Eculizumab (Soliris ) ELISA


作為Matriks Biotek在中國的區(qū)域代理,，科技有限公司將為中國客戶提供全面的Matriks Biotek以及客戶訂制化服務,。歡迎大家隨時聯(lián)系我們。    


會員登錄

×

請輸入賬號

請輸入密碼

=

請輸驗證碼

收藏該商鋪

X
該信息已收藏！
標簽：
保存成功

(空格分隔,最多3個,單個標簽最多10個字符)

常用：

提示

X
您的留言已提交成功,！我們將在第一時間回復您~
撥打電話
在線留言